Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The list format is native to the feed: a creator pointing at a caption that says your GLP subscription needs to get cancelled reads like advice, not an ad. Each sign is a specific frustration a current GLP-1 patient would recognize (paying a membership fee, paying more as the dose goes up, paying months upfront, struggling to cancel), and the second list answers them one for one with Eden's terms. That structure, problem list then matching answer list, makes the comparison easy to follow even with no voiceover.
Two things undercut the payoff. The fifth sign is feeling sick when you take it, and the matching answer is that Eden is made in US pharmacies it owns, which doesn't speak to that complaint, so the last beat feels like a dodge. And the close says to click the link in my bio, which is organic-post language that doesn't match a paid ad with a button. If you make one like this, drop any sign you can't answer directly, and end on a frame with the price and the actual next step (the free assessment) instead of a bio link.
It speaks to people who already pay for a GLP-1 elsewhere, which is the audience most likely to switch.
Each line names a specific frustration, so viewers check themselves against the list.
It answers the list item by item, which turns complaints into reasons to switch.
It asks for action, though in organic-post terms rather than pointing at the ad's button.
The answer list names one monthly price of $99 with no hidden fees, the same price at any dose and month-to-month billing.
The ad links to Eden's GLP-1 affiliate page, a focused landing page rather than a product page. The hero answers the video's list directly: one price per medication at every dose, an all-inclusive price with no annual plan required, and a free assessment that takes 3 minutes with no insurance needed. The ticker under the hero adds a lifetime price guarantee, which covers the dose-based pricing complaint, and the quality and clinical oversight section picks up the US-made point. Someone arriving from a creator's list will find the same promises in the same order of importance.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.